Curofy
Antacids Don't Improve Pulmonary Fibrosis Outcomes
Use of proton pump inhibitors or other antacid therapies does not appear to improve outcomes in patients with idiopathic pulmonary fibrosis (IPF), and the treatment may increase infection risk in patients with advanced disease, according to findings.
See this content immediately after install